LSC17 Score Is Complementary with Minimal Residual Disease to Stratify NPM1 -Mutated Acute Myeloid Leukemia: An ALFA Study - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Blood Année : 2022

LSC17 Score Is Complementary with Minimal Residual Disease to Stratify NPM1 -Mutated Acute Myeloid Leukemia: An ALFA Study

Loïc Vasseur
  • Fonction : Auteur

Dates et versions

hal-04020935 , version 1 (09-03-2023)

Identifiants

Citer

Loïc Vasseur, Laurène Fenwarth, Xavier Thomas, Jérôme Lambert, Stéphane de Botton, et al.. LSC17 Score Is Complementary with Minimal Residual Disease to Stratify NPM1 -Mutated Acute Myeloid Leukemia: An ALFA Study. Blood, 2022, 140 (Supplement 1), pp.6303-6305. ⟨10.1182/blood-2022-163348⟩. ⟨hal-04020935⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More